68475-503 NDC - CARMUSTINE (CARMUSTINE)

Drug Information

  • Product NDC: 68475-503
  • Proprietary Name: Carmustine
  • Non Proprietary Name: carmustine
  • Active Ingredient(s):
  • Administration Route(s):
  • Dosage Form(s): KIT

Labeler Information

Field Name Field Value
Labeler Name: Navinta LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA210179
Marketing Category: ANDA
Start Marketing Date:12/29/2020

Package Information

No. Package Code Package Description Billing Unit
168475-503-011 KIT in 1 CARTON (68475-503-01) * 3 mL in 1 VIAL (68475-502-01) * 30 mL in 1 VIAL, SINGLE-DOSE (68475-500-01)

NDC Record

Field Name Field Value Definition
PRODUCT NDC68475-503The translation of the route code submitted by the firm, indicating route of administration.
PRODUCT TYPE NAMEHUMAN PRESCRIPTION DRUGThis is the date that the labeler indicates was the start of its marketing of the drug product.
PROPRIETARY NAMECarmustineThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEcarmustineThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEKITAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
START MARKETING DATE12/29/2020 
MARKETING CATEGORY NAMEANDAProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
APPLICATION NUMBERANDA210179This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
LABELER NAMENavinta LLCName of Company corresponding to the labeler code segment of the Product NDC.

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025